Records containing: Idiopathic Gastroparesis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-10-28Coordination of Rare Diseases at Sanford
-
CLINICAL_TRIALS study results posted · 2026-09-24VP-VLY-686-3301: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase Iii Study To Assess The Efficacy Of Tradipitant In Relieving Symptoms Of Gastroparesis
-
CLINICAL_TRIALS study record update · 2026-04-22Biomagnetic Characterization of Gastric Dysrhythmias III
-
CLINICAL_TRIALS study record update · 2026-02-23A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis.
-
CLINICAL_TRIALS study record update · 2025-08-28A Phase 2 Randomized, Double-blind, Placebo-Controlled, Parallel-Group Study, of the Safety and Efficacy of NG101 Administered Orally to Patients With Gastroparesis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-07-24VP-VLY-686-3301: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase Iii Study To Assess The Efficacy Of Tradipitant In Relieving Symptoms Of Gastroparesis
-
CLINICAL_TRIALS study record update · 2025-05-29Coordination of Rare Diseases at Sanford
-
CLINICAL_TRIALS study record update · 2025-02-20A Multicenter, Open Label, 3-Month Safety Study with Tradipitant in Patients with Idiopathic or Diabetic Gastroparesis
-
CLINICAL_TRIALS study record update · 2024-05-24The NIDDK Gastroparesis Registry 3: Characterization and Clinical Course of Symptoms and Gastric Emptying in Patients With Symptoms of Gastroparesis
-
CLINICAL_TRIALS study record update · 2022-11-16A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2b Study to Evaluate the Efficacy and Safety of Twice-Daily Oral Administration of a Peripherally Acting Dopamine Receptor D2/D3 Antagonist, TAK-906 for the Treatment of Adult Subjects With Symptomatic Idiopathic or Diabetic Gastroparesis
-
CLINICAL_TRIALS study record update · 2022-02-23GpR 2: Continuation of the NIDDK Gastroparesis Registry for the Characterization and Clinical Course of Gastroparesis Patients
-
CLINICAL_TRIALS study record update · 2021-06-02Intraluminal Endosonography for Examination of the Structural Changes of the Stomach in Gastroparetic Patients
-
CLINICAL_TRIALS study record update · 2020-08-21Observational Study of the Efficacy and Outcomes of Gastric Peroral Endoscopic Myotomy (G-POEM) for Treatment of Refractory Gastroparesis
-
CLINICAL_TRIALS study record update · 2020-07-15A Dose-Ranging, Randomized, Parallel, Placebo-Controlled Study to Assess the Effect of TAK-954 on Gastrointestinal and Colonic Transit in Patients With Diabetic or Idiopathic Gastroparesis
-
CLINICAL_TRIALS study record update · 2019-09-10A Pilot Study on the Efficacy and Safety of Olanzapine in Improving Symptoms and Gastric Motility in Gastroparesis
-
CLINICAL_TRIALS study record update · 2015-04-16Nortriptyline for Idiopathic Gastroparesis: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial (NORIG)
-
CLINICAL_TRIALS study record update · 2015-04-01Effects of Global Osteopathic Manual Treatments on Patients With Idiopathic Gastroparesis